|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/00 | (2013.01) |
| A61K 47/42 | (2017.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 47/24 | (2013.01) | ||
| A61K 47/42 | (2013.01) | ||
| A61K 9/127 | (2006.01) | ||
| A61K 9/0048 | (2013.01) | ||
| A61K 45/00 | (2006.01) | ||
| A61K 47/24 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 27/06 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 27/10 | (2018.01) | ||
| A61P 27/06 | (2006.01) | ||
| A61P 27/12 | (2018.01) | ||
| A61P 27/10 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 27/12 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Number of the document | 3238746 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15873258.6 |
| Date of filing the European patent application | 2015-12-25 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2015/086203 |
| Date | 2015-12-25 |
| (87) | Number | WO 2016/104690 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 2014263018 | 2014-12-25 | JP |
| (72) |
SUDA, Kenji , JP
MURAKAMI, Tatsuya , JP
YOSHIMURA, Nagahisa , JP
GOTOH, Norimoto , JP
|
| (73) |
Kyoto University ,
36-1, Yoshida-honmachi
Sakyo-ku, Kyoto-shi, Kyoto 606-8501,
JP
NOSTA AG , Malzgasse 17,, 4052 Basel, CH |
| (54) | HIGH-DENSITY LIPOPROTEIN, AND DELIVERY OF DRUG TO POSTERIOR SEGMENT OF EYE BY OCULAR INSTILLATION OF SAID CYTOPHILIC PEPTIDE-FUSED HIGH-DENSITY LIPOPROTEIN |
| HIGH-DENSITY LIPOPROTEIN, AND DELIVERY OF DRUG TO POSTERIOR SEGMENT OF EYE BY OCULAR INSTILLATION OF SAID CYTOPHILIC PEPTIDE-FUSED HIGH-DENSITY LIPOPROTEIN |